Real-time biotech intelligence

Real-Time Biotech Catalyst Alerts

Track market-moving news from official sources and receive critical updates within minutes. BioPharmSignal is built for investors who want a cleaner, faster way to follow biotech catalysts.

Coverage

1000+ U.S.-listed biotech and pharma stocks

Sources

Press releases, SEC filings, FDA updates, trial results

Delivery

Critical alerts delivered within 5 minutes

What it does

Coverage, Trusted Sources, and Fast Delivery in One Quiet Workflow

BioPharmSignal reduces the work of monitoring biotech catalysts by keeping the highest-signal updates in one focused product.

Full Coverage

Track 1000+ biotech and pharma stocks listed in the U.S. without building or maintaining a manual list.

  • No market-cap restrictions
  • Focused coverage within one industry
  • Understand why a stock is moving

Official Sources

Company press releases, SEC filings, FDA approvals, and clinical trial results are the highest-signal inputs.

  • Company press releases
  • SEC filings
  • FDA approvals and trial news

Real-time News

Alerts are designed to arrive fast enough for catalyst-driven workflows, without making you refresh multiple tabs.

  • Continuous monitoring
  • Critical alerts within 5 minutes
  • Faster than traditional media coverage

Notification

Alerts That Stay Close to the Work in Front of You

Notification keeps delivery immediate and lightweight. You do not need to monitor inboxes or refresh multiple tabs to catch important biotech catalysts. When BioPharmSignal is added to the phone home screen, the same notification flow can also reach mobile.

Instant delivery

Critical biotech headlines arrive directly in the browser as they happen.

Mobile reach

When the page is added to a phone home screen, the same push flow can surface on mobile too.

Low friction

No inbox checking, no tab hunting, and no extra workflow to catch important catalysts.

Message notification

biopharmsignal.com

You have a new biotech catalyst alert, please review promptly

biopharmsignal.com/livefeed
AMGN2 min ago
9:415G

Saved app

BioPharmSignal

Investor Fit

Designed for Informed Biotech Investors

BioPharmSignal is built for users who already follow the events that drive biotech prices and want a cleaner way to stay current.

FDA approvals

SEC filings

Clinical trial results

Emerging biotech technologies

Risk management

1000+

stocks covered

5 min

delivery target

24/7

monitoring

Frequently Asked Questions

How fast are biotech alerts on BioPharmSignal?

BioPharmSignal is designed to surface critical biotech headlines within minutes whenever possible, especially for company press releases, FDA updates, SEC filings, and clinical trial news.

Do I need to build a biotech watchlist before using BioPharmSignal?

No. Coverage is automatic across the U.S.-listed biotech and pharma universe, so you can start with the livefeed and then narrow the view using saved tickers and keywords when needed.

What sources does BioPharmSignal track?

BioPharmSignal focuses on high-signal official and near-official sources, including company press releases, SEC filings, FDA updates, and clinical trial headlines that can move biotech stocks.

Who is BioPharmSignal built for?

The product is built for biotech investors, operators, and teams that need fast awareness of catalyst-driven updates without monitoring dozens of investor relations pages manually.

Can I track only a few biotech tickers or themes?

Yes. BioPharmSignal supports saved tickers and keywords so you can focus on a small watchlist, a handful of catalysts, or a broader theme such as obesity, oncology, or gene editing.

What kinds of biotech events usually show up in the livefeed?

Typical events include FDA decisions, PDUFA-related headlines, clinical readouts, partnership announcements, financing news, SEC filings, launch updates, and other catalyst-style company news.